Spots Global Cancer Trial Database for Atypical MOLes and Melanoma Early Detection Study (MoleMed)
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Atypical MOLes and Melanoma Early Detection Study (MoleMed)
Official Title: A Multicenter, Ambispective, Low-interventional Clinical Study Evaluating Molecular Genetic Markers for Non-invasive Differential Diagnosis of Benign and Malignant Pigmented Skin and Mucosal Neoplasms
Study ID: NCT04353050
Interventions
Study Description
Brief Summary: This is a multicenter, ambispective, low-interventional clinical study evaluating molecular genetic markers for non-invasive differential diagnosis of benign and malignant pigmented skin and mucosal neoplasms. In retrospective cohorts genetics markers will be identified. In prospective cohort non-invasive adhesive system will be tested to identify malignant or benign lesions with prespecified sensitivity and specificity compared to other non-invasive techniques (i.e. dermoscopy) and using histopathological examination as a "golden standard".
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Privolzhsky Research Medical University of the Ministry of Health of the Russian Federation, Nizhny Novgorod, , Russian Federation
N.N. Blokhin Russian Cancer Research Center, Moscow, Москва, Russian Federation
Contact Details
Name: Igor V Samoylenko, MD, PhD
Affiliation: N.N. Blokhin Russian Cancer Research Center of Russian MoH
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
